Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Symptom Management in African-American Men With Localized Prostate Cancer

This study has been withdrawn prior to enrollment.
(No subjects were enrolled here or at UCSF.)
Sponsor:
Information provided by (Responsible Party):
David Latini, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT00767845
First received: October 4, 2008
Last updated: November 7, 2016
Last verified: November 2016
  Purpose

RATIONALE: Gathering information about symptom management from patients with localized prostate cancer may help doctors improve patients' quality of life.

PURPOSE: This clinical trial is studying symptom management in African-American men with localized prostate cancer.


Condition Intervention
Prostate Cancer
Psychosocial Effects of Cancer and Its Treatment
Other: questionnaire/survey administration

Study Type: Observational
Official Title: PROSTATE CANCER SYMPTOM MANAGEMENT FOR LOW LITERACY MEN

Resource links provided by NLM:


Further study details as provided by Baylor College of Medicine:

Primary Outcome Measures:
  • Symptom management taxonomy

Enrollment: 0
Study Start Date: June 2006
Study Completion Date: May 2008
Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
Detailed Description:

OBJECTIVES:

  • Develop a symptom management intervention for African-American men treated for localized prostate cancer, with a particular emphasis on low health literacy men.

OUTLINE: Participants are interviewed by the principal investigator over the phone or meet the principal investigator at the Veterans Administration prostate cancer clinic. If the interview is conducted in the clinic, it is held in a private room in the clinic.

  Eligibility

Ages Eligible for Study:   18 Years to 120 Years   (Adult, Senior)
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

DISEASE CHARACTERISTICS:

  • Biopsy-proven localized prostate cancer

    • Has received treatment for prostate cancer
  • Patient self-identifies as being of African-American descent

PATIENT CHARACTERISTICS:

  • Able to speak and read in English
  • Has an address in order to receive study materials by mail (a street address or post office box)
  • Has either a telephone in order to be interviewed OR is able to meet the principal investigator at the Veterans Administration prostate clinic and be interviewed there

PRIOR CONCURRENT THERAPY:

  • See Disease Characteristics
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00767845

Locations
United States, Texas
Dan L. Duncan Cancer Center at Baylor College of Medicine
Houston, Texas, United States, 77030
Sponsors and Collaborators
Baylor College of Medicine
Investigators
Principal Investigator: David M. Latini, PhD Baylor College of Medicine
  More Information

Responsible Party: David Latini, Assistant Professor, Baylor College of Medicine
ClinicalTrials.gov Identifier: NCT00767845     History of Changes
Other Study ID Numbers: CDR0000600455  BCM-H-19323 
Study First Received: October 4, 2008
Last Updated: November 7, 2016
Health Authority: United States: Institutional Review Board

Keywords provided by Baylor College of Medicine:
psychosocial effects of cancer and its treatment
stage I prostate cancer
stage II prostate cancer
stage III prostate cancer

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Genital Diseases, Male
Prostatic Diseases

ClinicalTrials.gov processed this record on December 02, 2016